Morgan Stanley Amyris, Inc. Transaction History

Morgan Stanley

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.58 - $1.3 $39,588 - $88,732	68,256 Added 2.2%	3,174,232 $3.27 Million
Q1 2023 May 15, 2023	SELL	$1.09 - $1.82 $513,893 - $858,060	-471,462 Reduced 13.18%	3,105,976 $4.22 Million
Q4 2022 Feb 14, 2023	SELL	$1.52 - $3.39 $2 Million - $4.46 Million	-1,316,654 Reduced 26.9%	3,577,438 $5.47 Million
Q3 2022 Nov 14, 2022	BUY	$1.7 - $4.05 $962,920 - $2.29 Million	566,424 Added 13.09%	4,894,092 $14.3 Million
Q2 2022 Oct 27, 2022	BUY	$1.6 - $5.07 $516,139 - $1.64 Million	322,587 Added 8.05%	4,327,668 $8.01 Million
Q2 2022 Aug 15, 2022	BUY	$1.6 - $5.07 $516,139 - $1.64 Million	322,587 Added 8.05%	4,327,668 $8.01 Million
Q1 2022 Oct 27, 2022	SELL	$3.92 - $5.86 $1.26 Million - $1.89 Million	-322,587 Reduced 7.45%	4,005,081 $17.5 Million
Q1 2022 May 13, 2022	BUY	$3.92 - $5.86 $3.92 Million - $5.86 Million	1,000,422 Added 33.3%	4,005,081 $17.5 Million
Q4 2021 Feb 14, 2022	BUY	$5.0 - $14.85 $12.3 Million - $36.4 Million	2,451,972 Added 443.65%	3,004,659 $16.3 Million
Q3 2021 Nov 15, 2021	BUY	$12.13 - $16.99 $6.7 Million - $9.39 Million	552,687 New	552,687 $7.59 Million

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.